ReviewCurrent treatment options in oncology2025
Oral Budesonide in Oncology: A Novel Approach to Managing Gastrointestinal Immune-Related Adverse Events.
Piotr T Wysocki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it